Geneva, 26 May 2020 – Gavi has welcomed the announcement by New Zealand Deputy Prime Minister and Minister of Foreign Affairs Winston Peters that the country will commit NZ$ 7 million to Gavi, the Vaccine Alliance.
The funding will help protect children in the most vulnerable Pacific nations against deadly diseases like measles, polio and cervical cancer, as well as the response to the COVID-19 pandemic in lower-income countries.
The pledge marks New Zealand’s first contribution to a Gavi replenishment and comes less than two weeks ahead of the Global Vaccine Summit, hosted by the UK government on 4 June, which aims to raise at least US$ 7.4 billion for Gavi’s next five-year period.
“COVID-19 is proof on a global scale, of the devastation highly contagious illness can have when innocent populations are caught off guard,” Mr Peters said. “This funding has been targeted to support the vaccination of vulnerable children in our Pacific neighbourhood, protecting them from a number of high-risk diseases. The funding will also contribute to the ongoing COVID-19 pandemic response more widely. It is the responsibility of every nation to work together to tackle COVID-19 and to prepare for, and minimise, any future disease outbreaks.”
"The measles outbreak in the Pacific last year is a stark reminder of how important routine immunisation is. This holds true especially during the COVID-19 pandemic,” said Dr Ngozi Okonjo-Iweala, Gavi Board Chair. “By contributing to the Vaccine Alliance, today New Zealand is sending a strong message of solidarity to other nations and helping us to prevent the resurgence of other deadly, vaccine-preventable diseases. One pandemic is enough.”
Gavi currently supports the immunisation of children in four Pacific countries: Papua New Guinea, Timor-Leste, Kiribati and the Solomon Islands.
As well as continuing to support routine immunisation and vaccine campaigns in 68 countries, Gavi has made up to US$ 200 million available to help lower-income countries respond to the COVID-19 pandemic, US$ 71.3 million of which has been approved for 39 countries with acute needs. This funding is supporting the procurement of personal protective equipment (PPE), diagnostics and other vital medical equipment, as well as fund disease surveillance and communications activities.
“We are enormously grateful for this support, which will protect thousands of children against deadly disease,” said Dr Seth Berkley, Gavi CEO. “Not only that, this funding will also support our efforts to help health systems in some of the world’s poorest countries withstand the shock of COVID-19, both funding the PPE and diagnostics needed for countries to respond to this pandemic and helping to maintain the immunisation infrastructure needed to eventually deliver COVID-19 vaccines.”
Over the past two decades, Gavi has helped to immunise more than 760 million children, saving more than 13 million lives. Over that time, the Alliance has also worked to strengthen health systems in the world’s poorest countries and establish vaccine stockpiles against serious global health security threats, including Ebola.
HPV vaccine manufacturers commit to provide enough supply to immunise at least 84 million girls in Gavi countries
On the eve of the Global Vaccine Summit 2020, five manufacturers commit to increasing and prioritising HPV vaccine supply to Gavi-supported countries, which have among the highest cervical cancer burdens in the world.
Private sector partners strengthen Gavi programmes with more than US$ 70 million in contributions
The commitments build on the potency of public private partnerships, which have contributed to Gavi’s success.
Switzerland commits CHF 30 million to Gavi
Contribution will go towards Gavi’s efforts to deliver life-saving vaccines to children in the world’s poorest countries in 2021-2025 strategic period.
Italy deepens support for Gavi with €150 million IFFIm pledge
Pledge follows €120 million in direct funding to Gavi Italy announced at last month’s Coronavirus Global Response pledging conference.
Gavi receives US$ 5 million from The Rockefeller Foundation
Gavi receives US$ 5 million from the Rockefeller Foundation to support health workers facing COVID-19 pandemic
The UPS Foundation commits US$ 3 million to Gavi
UPS partnership with Gavi builds on successful efforts to expand and improve vaccine delivery in Uganda and some of the world’s most underserved communities.
New donor Greece pledges €1.5 million to Gavi COVID response
New funding for Gavi to support lower-income countries’ response to the COVID-19 pandemic, including supporting health systems.
New Zealand announces NZ$ 7 million pledge to Vaccine Alliance
Funding will support the response to the COVID-19 pandemic in lower-income countries as well as the vaccination of thousands of children in vulnerable Pacific nations.
Canada commits CAD 600 million to Gavi
Canada’s contribution will go towards Gavi’s efforts to deliver life-saving vaccines to children in the world’s poorest countries in 2021-2025 strategic period.